The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizamab for patients with unresectable colorectal liver-limited metastasis.
Robert C. G. Martin
Consultant or Advisory Role - Biocompatibles International
Charles R. Scoggins
No relevant relationships to disclose
William S. Rilling
No relevant relationships to disclose
Marshall T. Schreeder
No relevant relationships to disclose
John S. Kauh
No relevant relationships to disclose
Steven M. Strasberg
No relevant relationships to disclose
Todd S. Crocenzi
No relevant relationships to disclose
Rebecca Redman
No relevant relationships to disclose
Vivek R. Sharma
No relevant relationships to disclose